|
|
||||||||
Radiologic-Pathologic Conference of Wilford Hall Medical Center |
1 Department of Radiology, Wilford Hall Medical Center, Ste. 1, 2200 Bergquist
Dr., Lackland AFB, TX 78236-5300.
2 Penn State University College of Medicine, 500 University Dr., Hershey Medical
Center, Hershey, PA 17033.
3 Department of Radiology, Uniformed Services University of the Health Sciences,
4301 Jones Bridge Rd., Bethesda, MD 20814-4799.
Received December 2, 2002;
accepted after revision January 13, 2003.
Address correspondence to J. Q. Ly.
|
|
|
Intramuscular myxoma is a benign soft-tissue tumor primarily affecting patients 4070 years old. Slightly more than half the patients are women. In descending order of occurrence, the mass is most frequently located in the large muscles of the thigh, shoulder, buttocks, or upper arm [1]. The tumor may be surrounded by muscle tissue; attached on one side to muscle fascia; or extend from the periosteum, the subchondral epiphysis, or the joint capsule. Clinically, the tumor most often presents as a firm, painless, palpable, and slowly enlarging soft-tissue mass that is slightly mobile and sometimes fluctuant [2]. However, because the rate of tumor growth also varies, larger tumors with increased growth rates may present with pain, paresthesia, and muscle weakness caused by mass effect. Most intramuscular myxomas are solitary.
Histologically, intramuscular myxomas are composed of a few spindle-shaped cells interspersed within an abundant amount of mucoid substance overlying a loose reticulin framework [2]. It is believed that the tumor originates from modified fibroblasts producing increased amounts of glycosaminoglycans that prevent polymerization of healthy collagen. Gross specimen findings include an ovoid or globular gelatinous mass with scant cystlike areas nested in bundles of skeletal muscle or fascial tissue.
On radiography, an ill-defined soft-tissue density is noticeable [1]. Because of their high mucin and low collagen composition, intramuscular myxomas are sonographically hypoechoic and show low attenuation on CT. T1-weighted images typically show low signal intensity. T2-weighted images show high signal intensity with variable enhancement; most are heterogeneous and hyperintense [1]. Additionally, MRI may show a perilesional fat rind [1, 3]. Bancroft et al. [3] found that the identification of a perilesional fat rind on MRI and of increased signal intensity of the adjacent muscle on T2-weighted images increased the likelihood that a lesion was a myxoma and not a myxoid liposarcoma. Although these radiologic observations may not obviate tumor biopsy, they can aid in distinguishing pre-operatively between benign myxomas and malignant myxoid liposarcomas, two tumors that are often confused radiologically and pathologically [1, 3].
Percutaneous core biopsy provides definitive diagnosis of intramuscular myxoma. These benign tumors are usually treated by local surgical excision. Recurrences are rare and are successfully treated with reexcision.
|
|
|---|
This article has been cited by other articles:
![]() |
G. Girish, D. A. Jamadar, D. Landry, K. Finlay, J. A. Jacobson, and L. Friedman Sonography of intramuscular myxomas: the bright rim and bright cap signs. J. Ultrasound Med., July 1, 2006; 25(7): 865 - 869. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |